YOD1 and pancreatic adenocarcinoma: Subsequent studies found that these miRNAs were significantly enriched in cancer, cell adhesion, p53, TGF-β, Hippo and other cancer-related signaling pathways. Eight of the miRNAs were significantly correlated with OS of PAAD, possibly by inhibiting YOD1.